[Osteoporosis in patients under treatment for cancer and the possibilities for prevention and treatment]

Ned Tijdschr Geneeskd. 2007 Jun 23;151(25):1388-93.
[Article in Dutch]

Abstract

The treatment of cancer can have a negative influence on bone metabolism. This can result in the development of early osteoporosis or the aggravation of existing osteoporosis, with an increased risk of fractures. Depending on the duration and type of cancer therapy, prophylactic or therapeutic measures against osteoporosis may become necessary. The risk of osteoporosis may be assessed by screening with osteodensitometry, among other methods. Effective treatment is possible, for example with bisphosphonates.

Publication types

  • English Abstract
  • Review

MeSH terms

  • Antineoplastic Agents / adverse effects*
  • Antineoplastic Agents / therapeutic use
  • Bone Density / drug effects*
  • Bone Density Conservation Agents / therapeutic use*
  • Diphosphonates / therapeutic use*
  • Humans
  • Neoplasms / therapy
  • Osteoporosis / chemically induced*
  • Osteoporosis / prevention & control

Substances

  • Antineoplastic Agents
  • Bone Density Conservation Agents
  • Diphosphonates